earnings
NASDAQ · CUE
Cue Biopharma, Inc.
Healthcare · Biotechnology
$31.64
Up+$2.53 (+8.00%)
Updated Sep 16, 2026, 8:22 PM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 38.39M
- P/E ratio
- -1.2
- Dividend yield
- 0.00%
- 52-week range
- $0.17 – $45.50
- Volume
- 127.17K
- Avg. volume
- 291.36K
Price performance
CUE price history
1M range · 20 trading sessions · Daily adjusted prices
CUE closed at $31.64 after 20 trading sessions, up 23.11% for the selected period.
- Last close
- $31.64
- Period change
- +23.11%
- Period low
- $23.18
- Period high
- $31.64
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $30.65 | $32.00 | $29.26 | $31.64 | 127.17K |
| Sep 14, 2026 | $28.24 | $31.10 | $28.24 | $30.55 | 136.6K |
| Sep 11, 2026 | $28.38 | $28.89 | $27.50 | $28.74 | 122.77K |
| Sep 10, 2026 | $30.20 | $30.905 | $27.50 | $28.00 | 143.19K |
| Sep 9, 2026 | $30.00 | $32.13 | $30.00 | $30.50 | 174.15K |
| Sep 8, 2026 | $27.39 | $30.24 | $25.62 | $30.00 | 260.04K |
| Sep 4, 2026 | $27.55 | $27.95 | $27.025 | $27.44 | 50.42K |
| Sep 3, 2026 | $26.60 | $28.09 | $26.60 | $27.67 | 65.68K |
| Sep 2, 2026 | $28.32 | $28.93 | $25.04 | $26.96 | 127.87K |
| Sep 1, 2026 | $25.29 | $29.28 | $25.01 | $28.44 | 177.42K |
| Aug 31, 2026 | $27.48 | $28.9749 | $25.075 | $25.52 | 101.12K |
| Aug 28, 2026 | $28.64 | $29.75 | $26.8517 | $27.88 | 102.26K |
| Aug 27, 2026 | $28.85 | $29.20 | $26.38 | $28.16 | 225.52K |
| Aug 26, 2026 | $26.63 | $29.325 | $26.26 | $28.85 | 205.09K |
| Aug 25, 2026 | $23.69 | $28.29 | $23.405 | $26.76 | 170.47K |
| Aug 24, 2026 | $23.97 | $24.193 | $22.56 | $23.18 | 136.57K |
| Aug 21, 2026 | $25.55 | $26.00 | $23.235 | $23.98 | 177.75K |
| Aug 20, 2026 | $26.44 | $28.11 | $24.40 | $24.61 | 158.05K |
| Aug 19, 2026 | $26.46 | $27.20 | $25.17 | $26.28 | 166.44K |
| Aug 18, 2026 | $27.39 | $27.95 | $24.31 | $25.70 | 270.69K |
Latest CUE news
The latest Smart Investors Daily articles mentioning CUE.
Stock researchResearch & News · SEC Filings
Loading stock research…